Skip to content
Iopanoic acid
Telepaque (iopanoic acid) is a small molecule pharmaceutical. Iopanoic acid was first approved as Telepaque on 1982-01-01. It is used to treat hyperthyroidism in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
endocrine system diseasesD004700
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Iopanoic acid
Tradename
Company
Number
Date
Products
TELEPAQUEGE HealthcareN-008032 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
hyperthyroidism—D006980E05.9
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
— V08: Contrast media
— V08A: X-ray contrast media, iodinated
— V08AC: Watersoluble, hepatotropic x-ray contrast media
— V08AC06: Iopanoic acid
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameIOPANOIC ACID
INNiopanoic acid
Description
Iopanoic acid is a monocarboxylic acid.
Classification
Small molecule
Drug classiodine-containing contrast media
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O
Identifiers
PDB—
CAS-ID96-83-3
RxCUI5967
ChEMBL IDCHEMBL867
ChEBI ID5951
PubChem CID3735
DrugBankDB08946
UNII IDFE9794P71J (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 359 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details